The Journal of Steroid Biochemistry and Molecular Biology 2001: Vol 76 Index

5 Pages·2001·0.74 MB·English

PII: $0960-0760(01)00054-1
SUBJECT INDEX
Alzheimer’s disease
and estrogen, 227
Androgen(s)
receptor(s)
in syndromes of androgen insensitivity and in prostate cancer, 135
selective DNA binding by the, as a mechanism for hormone-specific gene regulation, 23
Antiestrogen(s)
control of the estrogen-like actions of the tamoxifen-estrogen receptor complex by the surface amino acid at position 351,
61
molecular and pharmacological aspects of, resistance, 71
Antisulfatase agents
in breast cancer, 95
Aromatase inhibitors
intracellular aromatase and its relevance to the pharmacological efficacy of, 199
recent advances in the clinical application of, 179
Assembly assay
new insights into receptor ligand binding domains from a novel, 3
Breast cancer
and enzyme activity, 95
molecular and pharmacological aspects of antiestrogen resistance in, 71
recent advances in the clinical application of aromatase inhibitors, 179
Breast cancer cells
estrogen regulated proteases and ‘antiproteases in ovarian and, 119
hormonal regulation of tumor suppressor proteins in, 105
Breast tumors
expression of the 11B-hydroxysteroid dehydrogenase type II enzyme in, and modulation of activity and cell growth in
PMC42 cells, 153
Cell nucleus
compartmentalization of regulatory proteins in the cell nucleus, 9
1 ,25-Dihydroxyvitamin D
effects of, on skeletal and calcium homeostasis and on inhibition of tumor cell growth, 43
DNA binding
selective, by the androgen receptor as a mechanism for hormone-specific gene regulation, 23
Endometrial cells
MHC class II expression and antigen presentation by human, 203
Estrogen(s)
Alzheimer’s disease and, 227
receptor(s)
paradoxical interactions among, estrogens and SERMS: mutual annihilation and synergy, 85
regulation of proteases and antiproteases by, in ovarian and breast cancer cells, 119
Gonadotropin
regulation by, of steroidogenic enzymes and novel gonadal genes, 187
Hormone-specific gene regulation
selective DNA binding by the androgen receptor as a mechanism for, 23
3B-Hydroxysteroid dehydrogenasel/A°’—A* isomerase
multiple signal transduction pathways mediate interleukin-4-induced, in normal and tumoral target tissues, 213
11B-Hydroxysteroid dehydrogenase type II
expression of the, enzyme in breast tumors and modulation of activity and cell growth in PMC42 cells, 153
17B-Hydroxysteroid dehydrogenase ,
analysis and characteristics of multiple types of human, 143
types in human breast cancer, 95
Interleukin-4
multiple signal transduction pathways mediate, -induced 3B-hydroxysteroid dehydrogenasel/A’—A* isomerase in normal
and tumoral target tissues, 213
Vv
Subject Index
Leydig cell
interaction of thyroid hormone and steroidogenic acute regulatory (StAR) protein in the regulation of murine,
steroidogenesis, 167
MHC class II expression
and antigen presentation by human endometrial cells, 203
mRNA
of sulfatase and sulfotransferase in human breast cancer, 95
Ovarian cancer cells
estrogen regulated proteases and antiproteases in, 119
Prostate cancer
androgen receptor in, 135
vitamin D and, 125
Pseudohermaphroditism
and human |7f-hydroxysteroid dehydrogenase type 3, 143
Receptor(s)
androgen(s)
in syndromes of androgen insensitivity and in prostate cancer, 135
selective DNA binding by the, as a mechanism for hormone-specific gene regulation, 23
estrogen(s)
paradoxical interactions among, estrogens and SERMS: mutual annihilation and synergy, 85
ligand binding domains
new insights into, from a novel assembly assay, 3
vitamin D
ligands for the, endocrine system, 49
Regulatory proteins
compartmentalization of, in the cell nucleus, 9
SEEM: selective estrogen enzyme modulator
in breast cancer, 95
SERM(s)
paradoxical interactions among estrogen receptors, estrogens and, mutual annihilation and synergy, 85
Steroid(s)
resistance to multiple, in two sisters, 161
Steroidogenic acute regulatory (StAR) protein
interaction of thyroid hormone and, in the regulation of murine Leydig cell steroidogenesis, 167
Steroidogenic enzymes
gonadotropin regulation of, 187
Sulfatase
action in breast cancer, 95
Sulfotransferase
action in breast cancer, 95
Syndromes of androgen insensitivity
the androgen receptor in, and in prostate cancer, 135
‘Tamoxifen
control of the estrogen-like actions of the, -estrogen receptor complex by the surface amino acid at position 351, 61
Thyroid hormone
interaction of, and steroidogenic acute regulatory (StAR) protein in the regulation of murine Leydig cell steroidogenesis
167
receptor(s)
selective modulation of, function by hormone analogs and protein-protein interactions, 31
Tibolone
a steroid with a tissue specific mode of action, 23]
effect of, on sulfatase activity in breast cancer, 95
Tumor cell growth
effects of 1,25-dihydroxyvitamin D on skeletal and calcium homeostasis and on inhibition of, 43
Tumor suppressor protein(s)
hormonal regulation of, in breast cancer cells, 105
Vitamin D
and prostate cancer, 125
ligands for the, endocrine system, 49
PII: S0960—0760(01)00053—X
AUTHOR INDEX
Ahonen M., 125 Ishizuka S., 49 PasqualiniJ . R., 1, 95
Aksenov N., 125 Iwasa K., 227 Pease K. M., 61
Alban P., 105 Peeters B., 23
Apriletti J. W., 31 Jhanwar S., 105 Pennanen P., 125
Avila D. M., 135 Johnson K., 203 Pissios P., 3
Jordan V. C., 61 Platet N., 119
Barron N., 161
Baxter J. D., 31 Kariya K., 227 Rochefort H., 119
Bazett-Jones D. P., 9 Kawata M., 227 Rombauts W., 23
Bentrem D. J., 61 Kaye A. M., 85 Roy P., 167
Bhatnagar A. S., 199 Khanum A., 187 Russo C., 161
Blauer M., 125 Khattree N., 105
Boisvert F.-M., 9 Kikuchi N., 227 Sasson S., 85
Bouker K. B., 71 Kinoshita Y., 227 Scanlan T. S., 31
Brandon D. D., 161 Kloosterboer H. J., 231 Schoenmakers E., 23
Brodie A. M. H., 199 Koyama K., 153 Simard J., 213
Kremer R., 43 Skaar T. C., 71
Chalbos D., 119 Krozowski Z., 153 Smith R., 153
Chetrite G. S., 95 Kruhlak M. J., 9 Somjen D., 85
Claessens F., 23 Spatz M., 85
Clark B. J., 167 Lee Y. R., 71 Stocco D. M., 167
Clarke R., 71 Leonessa F., 71 Syvala H., 125
Collins J. E., 203 Levenson A. S., 61
Coté S., 213 Lever M. A., 9 Tamir S., 85
Cunat S., 119 Long B. J., 199 Tamura T., 227
Cunningham-Rundles S., 161 Loriaux D. L., 161 Tanaka K., 227
Lou Y. R., 125 Tang P.-Z., 187
Davis N., 71 Lucas A., 119 Tsai-Morris C.-H., 187
Dillmann W. H., 31 Luu-The V., 143 Tuohimaa P., 125
Dinda S., 105 Lyakhovich A., 125 Tzameli L., 3
Dowsett M., 179
Dufau M. L., 187 MacGregor Schafer J. L., Urabe M., 227
MacLean N. A. B., 9
Evans D. B., 199 Manna P. R., 167 Vandermeulen J., 161
Manninen T., 125 Vaya J., 85
Fletterick R. J., 31 McPhaul M. J., 135 Verhoeven G., 23
Furlow J. D., 31 Miettinen S., 125 Verrijdt G., 23
Miller W. R., 199 Vilja P., 125
Garcia M., 119 Moore D. D., 3
Gingras S., 213 Moudgil V. K., 105 Waisman A., 85
Goltzman D., 43 Myles K., 153 Wallace P. K., 203
Guyre P. M., 203 Webb P., 31
Newfield R. S., 161 Welch J. N., 71
Haelens A., 23 New M. L, 161 West B. L., 31
Harper-Wynne C., 179 Nimkarn S., 161 White J., 43
Hasan T., 125 Norman A. W., 49 Wilson R. C., 161
Hendzel M. J., 9 Wira C. R., 203
Honjo H., 227 Ohkubo T., 227
Hosoda T., 227 Okamura W. H., 49 Yeaman G. R., 203
Huber R., 31 O'Malley B., 161 Ylikomi T., 125
Huhtaniemi I. T., 167
Hurd C., 105 Pasanen P., 125 Zoppi S., 135